China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered into a ...

BioJapan 2026, Regenerative Medicine JAPAN and healthTECH JAPAN, PACIFICO Yokohama, 7 to 9 October Forty years after its first edition in 1986, BioJapan opened its 2026 edition at PACIFICO Yokohama on ...

Docquity, the Singapore-based clinical AI platform for more than 75% of verified doctors across Asia, has announced its scale ...

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts, US.

NUS Enterprise has evolved into NUSX, an integrated venture-building and IP commercialisation platform using AI-powered research commercialisation and global outposts to help Singapore deep tech ...

NUS launches S$50M National Centre for Engineering Biology to accelerate AI-guided sustainable biomanufacturing ...

Germfree has launched a configurable Grade A aseptic biopharmaceutical isolator designed to support contamination control and ...

Merck, known as MSD outside of the United States and Canada, and China-based startup SciBrunch Therapeutics have entered into an exclusive global license agreement for SPR2015, an investigational ...

Vitalant has opened a cell-based analytics laboratory at the Phoenix Bioscience Core to expand donor characterisation, immune profiling and assay-development support for allogeneic therapy developers.

Australia's CSL inks $1.2 B deal with Swiss firm Alentis to develop lixudebart for rare kidney and liver diseases treatment ...

Chiba University and Noguchi Memorial Institute for Medical Research sign MOU to advance next-generation vaccine R&D ...

Terumo BCT, TrAMPoline Pharma and the University of Colorado are collaborating to automate manufacturing of genetically enhanced TIL therapies using the Quantum Flex Cell Expansion System.